UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

The cellular origins of drug resistance in cancer

Nature medicine, 2016-03, Vol.22 (3), p.232-234

Oxnard, Geoffrey R

2016

Link zum Volltext

Verfügbarkeit prüfen

New Targetable Oncogenes in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-03, Vol.31 (8), p.1097-1104

2013

Link zum Volltext

Verfügbarkeit prüfen

Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC

Scientific reports, 2016-09, Vol.6 (1), p.33860-33860, Article 33860

2016

Link zum Volltext

Verfügbarkeit prüfen

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M

Nature medicine, 2015-06, Vol.21 (6), p.560-562

2015

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

CA: a cancer journal for clinicians, 2021-03, Vol.71 (2), p.176-190

2021

Link zum Volltext

Verfügbarkeit prüfen

False positive plasma genotyping due to clonal hematopoiesis

Clinical cancer research, 2018-09, Vol.24 (18), p.4437-4443

2018

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

Clinical cancer research, 2014-03, Vol.20 (6), p.1698-1705

2014

Link zum Volltext

Verfügbarkeit prüfen

Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice

Nature reviews. Clinical oncology, 2021-01, Vol.18 (1), p.56-62

2021

Link zum Volltext

Verfügbarkeit prüfen

Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical Review

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1344-1356

2017

Link zum Volltext

Verfügbarkeit prüfen

New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer

Clinical cancer research, 2011-09, Vol.17 (17), p.5530-5537

2011

Link zum Volltext

Verfügbarkeit prüfen

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.1690-1700

2016

Link zum Volltext

Verfügbarkeit prüfen

Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients

Clinical cancer research, 2016-02, Vol.22 (4), p.915-922

2016

Link zum Volltext

Verfügbarkeit prüfen

Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

Clinical cancer research, 2012-02, Vol.18 (4), p.1167-1176

2012

Link zum Volltext

Verfügbarkeit prüfen

Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors

Cancer research (Chicago, Ill.), 2017-05, Vol.77 (10), p.2712-2721

2017

Link zum Volltext

Verfügbarkeit prüfen

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial

Clinical cancer research, 2021-08, Vol.27 (15), p.4160-4167

2021

Link zum Volltext

Verfügbarkeit prüfen

Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions

Journal of thoracic oncology, 2013-02, Vol.8 (2), p.179-184

2013

Link zum Volltext

Verfügbarkeit prüfen

Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer

Science translational medicine, 2013-12, Vol.5 (216), p.216ra177

2013

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA

Lung cancer (Amsterdam, Netherlands), 2019-08, Vol.134, p.96-99

2019

Link zum Volltext

Verfügbarkeit prüfen

EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas

Clinical cancer research, 2018-12, Vol.24 (24), p.6548-6555

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations

Cancer discovery, 2021-03, Vol.11 (3), p.591-598

2021

Link zum Volltext

Verfügbarkeit prüfen

Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients

Clinical cancer research, 2017-12, Vol.23 (23), p.7351-7359

2017

Link zum Volltext

Verfügbarkeit prüfen

The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA

Clinical cancer research, 2022-02, Vol.28 (4), p.728-737

2022

Link zum Volltext

Verfügbarkeit prüfen

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer

Clinical cancer research, 2015-12, Vol.21 (24), p.5439-5444

2015

Link zum Volltext

Verfügbarkeit prüfen

Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer

JAMA oncology, 2016-03, Vol.2 (3), p.313

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(291)

Publikationsform

Artikel
(323)
Buchkapitel
(1)

Sprache

Englisch
(323)
Japanisch
(58)

Erscheinungsjahr

n.n

Thema

Science & Technology
(159)
Life Sciences & Biomedicine
(155)
Humans
(145)
Oncology
(141)
Mutation
(75)
Lung Neoplasms - Genetics
(70)
Lung Neoplasms - Drug Therapy
(65)
Male
(61)
Carcinoma, Non-Small-Cell Lung - Genetics
(55)
Female
(55)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(53)
Lung Neoplasms - Pathology
(46)
Middle Aged
(45)
Aged
(40)
Carcinoma, Non-Small-Cell Lung - Pathology
(35)
Cancer Research
(33)
Adult
(32)
Lung Cancer
(31)
Protein Kinase Inhibitors - Therapeutic Use
(30)
Tumors
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The cellular origins of drug resistance in cancer

New Targetable Oncogenes in Non–Small-Cell Lung Cancer

Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

False positive plasma genotyping due to clonal hematopoiesis

Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice

Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical Review

New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients

Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial

Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions

Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer

Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA

EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas

Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations

Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients

The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer

Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer

Suchergebnisse filtern